Several departments in Shenzhen have collaborated to introduce measures aimed at supporting the entire value chain of the pharmaceutical and medical device industry. These measures emphasize the establishment of AI-driven R&D platforms and industrial projects, encompassing domains like novel drug development and biomanufacturing. The objective is to facilitate the broad adoption of AI technology in the R&D of pharmaceuticals and medical devices, as well as throughout the biomanufacturing process.
